Volf I - Search Results

1

Oxidized low-density lipoprotein is localized in the ventricles of hearts from patients with coronary heart disease.

Ekmekcioglu C, Mehrabi MR, Glogar HD, Jucewicz M, Volf I, Spieckermann PG. Ekmekcioglu C, et al. Among authors: volf i. Int J Clin Lab Res. 2000;30(3):133-40. doi: 10.1007/s005990070012. Int J Clin Lab Res. 2000. PMID: 11196071

2

Spectrophotometric determination of ascorbic acid and dehydroascorbic acid.

Moeslinger T, Brunner M, Volf I, Spieckermann PG. Moeslinger T, et al. Among authors: volf i. Clin Chem. 1995 Aug;41(8 Pt 1):1177-81. Clin Chem. 1995. PMID: 7628094

3

Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein.

Volf I, Moeslinger T, Cooper J, Schmid W, Koller E. Volf I, et al. FEBS Lett. 1999 Apr 23;449(2-3):141-5. doi: 10.1016/s0014-5793(99)00437-8. FEBS Lett. 1999. PMID: 10338120 Free article.

4

Urea induces macrophage proliferation by inhibition of inducible nitric oxide synthesis.

Moeslinger T, Friedl R, Volf I, Brunner M, Baran H, Koller E, Spieckermann PG. Moeslinger T, et al. Among authors: volf i. Kidney Int. 1999 Aug;56(2):581-8. doi: 10.1046/j.1523-1755.1999.00570.x. Kidney Int. 1999. PMID: 10432397 Free article.

5

Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line.

Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann PG. Moeslinger T, et al. Among authors: volf i. FEBS Lett. 2000 Jul 28;478(1-2):95-9. doi: 10.1016/s0014-5793(00)01825-1. FEBS Lett. 2000. PMID: 10922476 Free article.

6

Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL.

Volf I, Roth A, Cooper J, Moeslinger T, Koller E. Volf I, et al. FEBS Lett. 2000 Oct 20;483(2-3):155-9. doi: 10.1016/s0014-5793(00)02104-9. FEBS Lett. 2000. PMID: 11042272 Free article.

7

Inhibition of inducible nitric oxide synthesis by the herbal preparation Padma 28 in macrophage cell line.

Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann PG. Moeslinger T, et al. Among authors: volf i. Can J Physiol Pharmacol. 2000 Nov;78(11):861-6. Can J Physiol Pharmacol. 2000. PMID: 11100933

8

Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.

Volf I, Roth A, Moeslinger T, Cooper J, Schmid W, Zehetgruber M, Koller E. Volf I, et al. Thromb Res. 2000 Mar 15;97(6):441-9. doi: 10.1016/s0049-3848(99)00197-8. Thromb Res. 2000. PMID: 10704653

9

Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist.

Volf I, Bielek E, Moeslinger T, Koller F, Koller E. Volf I, et al. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):2011-8. doi: 10.1161/01.atv.20.8.2011. Arterioscler Thromb Vasc Biol. 2000. PMID: 10938025

10

SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux.

Pagler TA, Rhode S, Neuhofer A, Laggner H, Strobl W, Hinterndorfer C, Volf I, Pavelka M, Eckhardt ER, van der Westhuyzen DR, Schütz GJ, Stangl H. Pagler TA, et al. Among authors: volf i. J Biol Chem. 2006 Apr 21;281(16):11193-204. doi: 10.1074/jbc.M510261200. Epub 2006 Feb 16. J Biol Chem. 2006. PMID: 16488891 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters